Company / Shareholders' Equity
Sunshine Biopharma Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$23.5M
FY2025
5-year range
-$954.8K / $23.5M
FY2021-FY2025
Trend
+10.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from -$954,837 in FY2021 to $24M in FY2025.
Based on SEC 10-K filings.
$24M in FY2025 with a 3-year CAGR of +380.6%.
Improved from $22M to $24M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +380.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +380.6%, indicating consistent growth.
- In FY2025, shareholders' equity increased 10.8% year-over-year.
- Lowest shareholders' equity in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.5M | +10.8% |
| FY2024 | $21.2M | -1.9% |
| FY2023 | $21.6M | +10118.0% |
| FY2022 | $211.7K | +122.2% |
| FY2021 | -$954.8K | -29.8% |
| FY2020 | -$735.4K | -1219.0% |
| FY2019 | -$55.8K | +90.3% |
| FY2018 | -$573.4K | -173.4% |
| FY2017 | -$209.7K | +64.9% |
| FY2016 | -$597.0K | -54.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026